SEDA-Q
DEAD

Serial Number

88939015

Owner

BioQ Pharma, Inc.

Attorney

Thomas W. Galvani

First Use Date

Dec 31, 2019

Filing Date

May 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SEDA-Q Trademark

Serial Number: 88939015

SEDA-Q is a trademark filed by BioQ Pharma, Inc. on May 29, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

BioQ Pharma, Inc. (5 trademarks)

San Francisco, CA 94103

Entity Type: 03

MADRYN BIOQ SPV, LLC

330 MADISON AVENUE, 33RD FLOOR
NEW YORK, NY 10017

Entity Type: 16

Trademark Details

Filing Date

May 29, 2020

Registration Date

Not Registered

First Use Anywhere

December 31, 2019

First Use in Commerce

December 31, 2019

Published for Opposition

October 13, 2020

Goods & Services

Surgical apparatus and instruments for medical, dental and veterinary use for performing parenteral infusions in the field of medical and surgical procedures; Medical devices, namely, parenteral infusion pumps and dispensers for delivering measured amounts of solutions into the bloodstream over time; Medical infusion pumps for delivering measured amounts of solutions into the bloodstream over time

Pharmaceutical and veterinary preparations for the treatment of medical disorders treatable by parenteral infusion therapy, namely, pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases, and metabolic diseases and for induction and maintenance of anesthesia; Sterile preparations for medical purposes in clinical treatment for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Medicinal preparations for pharmaceutical purposes for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Drug delivery agents in the form of pharmaceutical infusion pumps that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 9, 2026 ASGN
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 4, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 4, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 23, 2021 CNRT
STATEMENT OF USE PROCESSING COMPLETE
May 21, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 21, 2021 AITU
USE AMENDMENT FILED
May 12, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
May 12, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 8, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 13, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 13, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 23, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 4, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 4, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 4, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 4, 2020 CNEA
ASSIGNED TO EXAMINER
Sep 1, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2020 NWOS
NEW APPLICATION ENTERED
Jun 2, 2020 NWAP